🇺🇸 glycerin suppository in United States
33 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 33
Most-reported reactions
- Diarrhoea — 6 reports (18.18%)
- Nausea — 5 reports (15.15%)
- Constipation — 4 reports (12.12%)
- Vomiting — 4 reports (12.12%)
- Fatigue — 3 reports (9.09%)
- Oral Intake Reduced — 3 reports (9.09%)
- Abdominal Discomfort — 2 reports (6.06%)
- Anaemia — 2 reports (6.06%)
- Back Pain — 2 reports (6.06%)
- Blood Creatinine Increased — 2 reports (6.06%)
Other Gastroenterology approved in United States
Frequently asked questions
Is glycerin suppository approved in United States?
glycerin suppository does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for glycerin suppository in United States?
University of Rochester is the originator. The local marketing authorisation holder may differ — check the official source linked above.